Azithromycin (a macrolide-like antibiotic) has antimalarial effects in
vitro and in animal models. In the course of a randomised trial of tr
achoma control we examined the effects of azithromycin on parasite and
spleen rates in the population aged 5-14 years from eight villages in
the Farafenni study area in The Gambia, West Africa. The entire popul
ation of four treatment villages received three doses of azithromycin
20 mg/kg weekly (days 1, 8, and 15) and four control villages received
daily tetracycline eye ointment topically (days 1-42). Among 226 chil
dren studied before treatment and at day 28, reduced the proportions w
ith Plasmodium parasites (rate ratio 0.56, 95% confidence interval 0.4
4-0.71; p<0.0001), with palpable spleens (RR 0.50, 95% CI 0.36-0.70; p
<0.0001), with febrile parasitaemia (RR 0.45, 95% CI 0.27-0.75; p<0.01
), and with P malariae infection (p<0.001). This effect was related mo
re to resolution of parasitaemia than to prevention of new infections.